Details of the Drug

General Information of Drug (ID: DMWFD3K)

Drug Name
Apristor
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Phase 2 [1]
Cross-matching ID
TTD ID
D0FA0A

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)